Home Health News Ozempic Shows Potential for Alcohol Addiction in Trial By News Health 1 month Ago Share on FacebookShare on Twitter (MedPage Today) — Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving in adults with alcohol use disorder (AUD), a phase II randomized trial showed. At 9 weeks, semaglutide… Source link : https://www.medpagetoday.com/psychiatry/addictions/114191 Author : Publish date : 2025-02-12 18:44:07 Copyright for syndicated content belongs to the linked Source. Categories: Health News Related Content Future of Canadian Guidelines, Task Force in Doubt By News Health March 18, 2025 Diabetes Study's Funding Yanked; Marriage-Obesity Link; CVS 'Menopause-Friendly' By News Health March 18, 2025 Pembrolizumab-Olaparib Boosts PFS in Non-BRCA Ovarian Cancer By News Health March 18, 2025 NICE Recommends Annual BMI Checks for Long-Term Conditions By News Health March 18, 2025 'Reasonable precautions' could have stopped baby deaths By News Health March 18, 2025 Later Cancer Diagnoses Increase Higher in Certain States By News Health March 18, 2025